Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

This economic evaluation study compares the costs of intravitreal injections of aflibercept, 2 mg, vs pars plana vitrectomy plus panretinal photocoagulation for nonclearing vitreous hemorrhage secondary to proliferative diabetic retinopathy.

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Ophthalmol
Glavni autori: Young, Benjamin K., Johnson, Mark W., Wubben, Thomas J.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Research Letter
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160925/
https://ncbi.nlm.nih.gov/pubmed/34042958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2021.1565
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items